Investing in choices – Psychedelics in Australia

Investing in choices – Psychedelics in Australia

29 Jul 2022
0:00
0%
0:00
|
0:00
https://cdn.streamly.video/Justin_James_fb60a1ee14.png
PREVIEW
Description

In this video, the CEO of not-for-profit health insurer HIF, Justin James discusses nature of psychedelics and medicinal cannabis. He describes the landscape for both in Australia and the genuine success stories which are emerging. Justin shares fascinating insights on how HIF is investing in choices like this and their desire to reduce the negative connotations associated with these substances. It will be interesting to see how Australia will increase its presence in the global market for psychedelics. Key words: Psychedelics; medicinal cannabis; health insurance; health fund; alternative therapies; medical marijuana; medical research

Table Of Contents

Why is the CEO of a health insurance company here to talk about emerging therapies like medicinal cannabis and psychedelics?
HIF was the first health insurer to publicly support medicinal cannabis. Can you tell me about your partnership with Little Green Pharma?
The psychedelic landscape in Australia: what does it look like?
How do we compare to other parts of the world?
What are some of the stigmas associated with medicinal cannabis and psychedelics? Where do you believe they originated?
How does HIF intend to eliminate the stigma associated with these emerging therapies?
What do these emerging therapies mean for private health insurance?
0
Your cart